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The treatment in the resistant forms has resulted effec-120 14
olding promise as a target for discriminatory genus iden-
iﬁcation of Mucormycota.
oi:10.1016/j.ijid.2010.02.1750
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Background: Recognition of epidemiologi-
al,etiological,topographical and treatment aspects.
n this study are included 45 cases,18-35 yearsold, during
he years 1999—2008 with recurrent (at least 4 episodes
f fungal infections in a year)/resistant (which doesn’t
espond to antifungal therapy) fungal infections.
Methods:We have analyzed the group-ages,the origin and
he immunity state of the patients.We have determined the
tiology,topographic variant of the fungal infections and the
eal sensibility against antifungal drugs (Ketoconazol, Intra-
onazol,Fluconazol,Clotrimazol).
Results: Epidemiologic:
roup-ages Number of cases
8-21 1
2-25 8
6-30 11
1-35 25
Where 28 were citizien, and 17 were peasants.
The immune state:
a) immunocompetent-30 cases
) immune-compromised-15 cases
iagnosis Number of cases
IV 4
olagenosis 4
iabetes Mellitus 2
ymphoma 1
isceral Leishmania 1
ypogamaglobulinemi 1
hyrotoxicosis 1
hronic hepatitis 1
Disease-topographic:Oro-pharyngeal fungal infection-42
ases
opography Number of caseseilitis 6
lositis 9
haryngitis 5
harynx—esophagitis 4
t
7
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Disease-topographic:dermal-16
opography Number of cases
xillary 1
ubmamare 2
nguinal 3
luteal 3
ntradigital 4
Disease-topographic:vulvovaginale -26
opography Number of cases
nal-perianal 2
nicomycosis 2
Etiologic:Candida albicans -33 cases
Candida glabriatra -5 cases
Trichophyton-6 cases
Criptoccocus Laurens-1 case.
Therapeutic:According to mycogram,the clinical
esponse and the subject quality.
-In (19) resistant cases we have:
a) repeated the therapeutic cycle(in 11 cases)
) extended the local treatment(10 cases),
c) associated the systemic treatment(16 cases),
) changed the antifungal drugs(13 cases).
We have done diagnose reconﬁrmation(2 cases from 8 has
esulted misdiagnosed).
3 from 5 cases with candida glabriata were resistand
gainst azole.
-In (26) recurrent cases we have applied the treatment
ith (Fluconazol 100 mg(p.o)or supp.Cotrimazol 500mg 1
ime/week until 6 month)
In 14 cases, after the treatment of recurrent
pisodes(ﬂuconazol 100—200mg/day/7—14 days) we
ave improved the management of immunecompromised
disease of subjects in 13 cases.
Conclusion: The recurrent/resistant fungal infections are
ncountered more frequently in group-ages 31-35 years-
ld,54% of all cases.
33% were immune-compromised;
67% were immune-competent (women).
6% of all cases were named as idiopathic,the long-term
reatment resulted ineffective.
Vulvo-vaginal fungal infections were predominated in
7.7% of cases.
The most frequent etiologic cause was Candida albi-
ans(73.3%).
The resistant fungal infections were 42.2% of all cases;
ecurrent 57.7%.ive in 84.2% and ineffective in 15.7%;in the recurrent forms
3.1% effective and 26.9% ineffective.
oi:10.1016/j.ijid.2010.02.1751
